LUPIN LTD (LUPIN) - Live BSE, NSE Stock Quotes - LUPIN LTD Analysis Update - Equitymaster.com
X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2015 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
McAfee Secure sites help keep you safe from identity theft, credit card fraud, spyware, spam, viruses and online scams
 

Dear Visitor: Equitymaster will be under maintenance from 06:00 AM to 08:30 AM IST on Saturday 30th May. Our website will not be accessible during this period. We regret the inconvenience caused. However, post this upgrade we will make it up to you in terms of a better browsing experience!

LUPIN LTD   (LUPL)
REFRESH
 Live BSE Quotes May 29, 2015 (Close)
Price (Rs)
1,831.90
Open (Rs)
1,750.00
High (Rs)
1,858.15
Low (Rs)
1,728.40
% Change
4.94
Volume
355,914
Value (Rs)
643,505,881
52-Week H/L
2,112.00 / 914.00

 Live NSE Quotes May 29, 2015 (Close)
Price (Rs)
1,833.25
Open (Rs)
1,749.90
High (Rs)
1,854.90
Low (Rs)
1,727.30
% Change
5.07
Volume
24,029,112
Value (Rs)
43,676,786,280
52-Week H/L
2,115.00 / 913.05

 Valuation
EPS (Rs)*
53.47
P/E Ratio (x)
34.26
Market Cap (Rs m)
823,420.73
P/BV (x)
11.88
 
*Trailing 12 months earnings, excluding extraordinary / exceptional items.
BSE Sensex | CNX Nifty
LUPIN LTD Stock Price Chart (Rs) - 1 Year
Loading...
  
PEER GROUP: QUOTE & GRAPH
MOVING AVERAGES 15 DMA 30 DMA 100 DMA 200 DMA
COMPARE WITH BSE-30 NSE-50 COMPANY COMPANY
VALUATION P/E Ratio P/BV COMPARE  S&P BSE SENSEX 
  PERIOD
 DO YOU LIKE OUR NEW GRAPHS? TELL US!  

Related Views On News

Cipla Limited: On a growth drive (Cool Hand Luke)

Mar 21, 2014

Luke Verghese discusses that Cipla's financials are on a roll

GSK pharma's Open offer: Our view (Company Info)

Dec 17, 2013

Should investors take advantage of the buy back offer and offload shares of GSK Pharma?

Foreign investment in pharma; walking a thin line (What We're Reading)

Oct 9, 2013

Here is today's recommended reading list from Equitymaster...

Divi's Laboratories: Cash rich operations (Cool Hand Luke)

Sep 24, 2013

Luke Verghese discusses that Divi's Laboratories is professionally managed

Sun Pharma Advanced Research: Strong R&D focus (Cool Hand Luke)

Sep 18, 2013

The Company is being very judiciously funded through permanent capital, and unsecured debt at favourable terms

More Views on News

Most Popular

Of Infosys, Shriram Transport and 20-30% corrections(The 5 Minute Wrapup)

May 22, 2015

Here's what you should do when you see 20-30% change in stock prices within days.

Looking Behind The Smokescreen(The Daily Reckoning)

May 23, 2015

This online event titled 'Looking Behind The Smokescreen With Vivek Kaul' was held on 5 PM on 19th May, 2015. View now!

Capital First: Improvement in profit margins

May 16, 2015

Capital First announced its results for the fourth quarter and financial year 2014-15 (FY15). The institution grew its income from operations by 34.4% YoY and the profits by 116.9% YoY during FY15.

Vinati Organics: A dull end to a strong year

May 21, 2015

Equitymaster presents Vinati Organics' results for the quarter and year ended March 2015.

Should you depend on Jan Bima Yojanas of Modi Government?(Mutual Fund Corner)

May 21, 2015

The Pradhan Mantri Suraksha Bima Yojna and Pradhan Mantri Jeevan Jyoti Bima Yojana were announced by the Government in the Union Budget 2015-16. PersonalFN explains and shares its views on these schemes.

More

TRACK LUPIN LTD

  • Track your investment in LUPIN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

LUPIN LTD - TEVA PHARMA COMPARISON

Compare Company With Charts

COMPARE LUPIN LTD WITH

MARKET STATS

  1. Go